Skip to content
OpenCapital
Get started

Utah Medical Products UTMD FX & Other Adjustments

FX & Other Adjustments at other companies

TFX
TeleflexTFX
-$10.99M-182%
UFP Technologies logo
UFP TechnologiesUFPT
-$755K-184%
Medline, Inc. logo
Medline, Inc. MDLN
——
Baxter International logo
Baxter InternationalBAX
——
Medtronic logo
MedtronicMDT
——

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K—
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity0×—
Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.

The official record: Utah Medical Products’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's fx & other adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's FX & other adjustments?
Utah Medical Products (UTMD) reported FX & other adjustments of $472K in Q4 2025.
How has Utah Medical Products's FX & other adjustments changed year-over-year?
Utah Medical Products's FX & other adjustments increased by 521.4% year-over-year, from -$112K to $472K.
What does FX & other adjustments mean?
This metric represents the impact of exchange rate fluctuations on the value of goodwill held in foreign currencies. It reflects non-cash gains or losses recognized when translating the carrying value of international assets into the reporting currency. Investors monitor this to understand how currency volatility affects the balance sheet valuation of acquired international businesses.